Feasibility study investigating the efficacy and safety of hybeid endoscopic submucosal dissectio
Not Applicable
- Conditions
- Colorectal adenoma/intramucosal cancer
- Registration Number
- JPRN-UMIN000022545
- Lead Sponsor
- TT Medical Center Tokyo Department of Gastroenterology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
We exclude patients with colorectal adenoma/intramucosalcancer larger than 30mm. Patients whose lesions were found to be outside the guideline or expanded criteria for ESD by the endoscopic characteristics and histological findings of biopsy specimens. Patients in disagreement with informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complication rate assessed after endoscopic treatment
- Secondary Outcome Measures
Name Time Method Procedure time, The rate of adverse events (perforation, delayed bleeding) These autcomes were assessed one Month after the treatment